A quality improvement project to address the challenges surrounding zoledronic acid use in children

INTRODUCTION: Zoledronic acid (ZA) is an intravenous bisphosphonate used to treat pediatric osteoporosis. Adverse events including hypocalcemia and acute phase reaction (APR) are common following first-infusion. The purpose of this report is to describe implementation of a ZA clinical practice guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, David R., Diaz, Maria Cristina Gil, Louis, Silvia, Rackovsky, Noya, Rahmani, Roman, Stauber, Sierra D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025437/
https://www.ncbi.nlm.nih.gov/pubmed/33825940
http://dx.doi.org/10.1007/s00774-021-01214-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025437/
https://www.ncbi.nlm.nih.gov/pubmed/33825940
http://dx.doi.org/10.1007/s00774-021-01214-5

Ejemplares similares